Home
About Us
Company Profile
Development History
Corporate Culture
Production Quality
Products&Services
Product Center
Research and Development
CDMO
Business Layout
Investor
Events
Press Releases
Contact Us
Chinese
English
日本語
Product Catalog
→ Small molecule compound
→ Commercialized Active Pharmaceutical Ingredient
→ Active pharmaceutical ingredients under development
→ Polypeptide compounds
Commercialized Active Pharmaceutical Ingredient
Product Name
CAS Number
Specification
TP
DMF
Status
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
√
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
Trametinib dimethyl sulfoxide
1187431-43-1
Tofacitinib Citrate
540737-29-9